ORBIMED ADVISORS LLC

Position in MRK — Merck & Co., Inc.

CIK 1055951 New York, NY

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$85,246,900

+$5,446,514 QoQ

Shares Held

663,400

0.0% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

1.69%

of 13F equity value

Holder Rank

#227

of 3,769 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $634,822,752 across 5 Drug Manufacturers - General names. MRK ranks #3 (13.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	257,900	$309,333,022
2	AZN	Astrazeneca PLC	915,700	$173,635,034
3	MRK	Merck & Co., Inc. This page	663,400	$85,246,900
4	BMY	Bristol Myers Squibb Co	925,000	$53,298,500
5	BIIB	Biogen Inc.	61,600	$13,309,296

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$85,246,900	663,400	0.0%	Shares	Sole	2026-08-14
2026-03-31	$79,800,386	663,400	-20.1%	Shares	Sole	2026-05-15
2024-12-31	$82,558,452	829,900	-36.9%	Shares	Sole	2025-02-14
2024-09-30	$149,444,960	1,316,000	0.0%	Shares	Sole	2024-11-14
2024-06-30	$162,920,800	1,316,000	0.0%	Shares	Sole	2024-08-14
2024-03-31	$173,646,200	1,316,000	+24.7%	Shares	Sole	2024-05-15
2023-12-31	$115,016,100	1,055,000	0.0%	Shares	Sole	2024-02-14
2023-09-30	$108,612,250	1,055,000	-40.7%	Shares	Sole	2023-11-14
2021-12-31	$136,365,552	1,779,300	-52.3%	Shares	Defined	2022-02-14
2021-09-30	$280,340,564	3,732,400	0.0%	Shares	Defined	2021-11-15
2021-06-30	$290,268,748	3,732,400	0.0%	Shares	Defined	2021-08-16
2021-03-31	$287,730,871	3,732,400	+40.4%	Shares	Defined	2021-05-17
2020-12-31	$217,530,642	2,659,300	+2.7%	Shares	Defined	2021-02-16
2020-09-30	$214,765,944	2,589,100	0.0%	Shares	Defined	2020-11-16
2020-06-30	$200,215,189	2,589,100	0.0%	Shares	Defined	2020-08-14
2020-03-31	$199,205,271	2,589,100	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.